Bioline Ltd.

Founded in 1992 and headquartered in London, UK, Bioline is an evolving international company and our mission is to provide customers with a range of products which are fast and easy to use, guaranteed to work and developed by scientists who understand what our customers are trying to achieve so they can focus on their scientific goals. At Bioline, we constantly strive to improve and to deliver high-quality products which are the result of our strong commitment and investment in science. Bioline, wholly owned by Meridian Bioscience Inc. (Nasdaq: VIVO), operates as one multi-cultural global team with strong values.

Meridian Bioscience is a public company with over 650 employees, 13 worldwide locations and in business for over 40 years.  Meridian's shares are traded through NASDAQ's Global Select Market, symbol VIVO.   Meridian is a fully integrated company with two business units dedicated to diagnostics and life science.   Meridian manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified antigens and antibodies for immunological tests and PCR amplification enzymes, master mixes and nucleotides for molecular diagnostics.  Our diagnostic products provide accuracy, simplicity, and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases, respiratory infections and lead poisoning.  Our life science unit, with large-scale manufacturing capabilities and over 3500 products,  provides the most comprehensive portfolio of raw materials for the clinical development of any immunological or molecular test.  Meridian operates under an ISO 13485 quality system.